{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:21:58Z","timestamp":1788312118276,"version":"build-2803163510"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter- Rhyner-Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009736","name":"Freiwillige Akademische Gesellschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009736","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227600","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T13:30:05Z","timestamp":1578922205000},"page":"e0227600","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania \u2013 A prospective cohort study"],"prefix":"10.1371","volume":"15","author":[{"given":"Rahel E.","family":"Bircher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Ntamatungiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Mnzava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Nyuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herry","family":"Mapesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klimkait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-1929","authenticated-orcid":true,"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the KIULARCO study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"pone.0227600.ref001","unstructured":"Estimates A. Country factsheets UNITED REPUBLIC OF TANZANIA | 2018 HIV and AIDS Estimates Adults and children living with Country factsheets UNITED REPUBLIC OF TANZANIA | 2018 HIV testing and treatment cascade People living with HIV Coverage of adults and children. 2018;1\u20137."},{"key":"pone.0227600.ref002","unstructured":"UNAIDS data 2018. https:\/\/www.unaids.org\/en\/resources\/documents\/2018\/unaids-data-2018"},{"key":"pone.0227600.ref003","unstructured":"NACP. NATIONAL GUIDELINES FOR THE MANAGEMENT OF HIV AND AIDS Sixth Edition October 2017. 2017;(October)."},{"issue":"7","key":"pone.0227600.ref004","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/jac\/dkw051","article-title":"HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults","volume":"71","author":"C Hawkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"pone.0227600.ref005","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/jac\/dkx095","article-title":"Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression","volume":"72","author":"AJ Ntamatungiro","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"pone.0227600.ref006","first-page":"1","article-title":"The treatment cascade in children with unsuppressed viral load\u2014a reality check in rural Lesotho, Southern Africa","volume":"77","author":"TI Lejone","year":"2017","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0227600.ref007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: An emerging public health concern","volume":"31","author":"L Muri","year":"2017","journal-title":"Aids"},{"issue":"9883","key":"pone.0227600.ref008","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S0140-6736(13)61164-2","article-title":"Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND","volume":"381","author":"M Boyd","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"pone.0227600.ref009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pone.0032144","article-title":"Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa","volume":"7","author":"JH Levison","year":"2012","journal-title":"PLoS One"},{"key":"pone.0227600.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178942","article-title":"Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy","author":"J Sv\u00e4rd","year":"2017"},{"issue":"July","key":"pone.0227600.ref011","first-page":"1","article-title":"Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO)\u2014A prospective HIV cohort in rural Tanzania","volume":"147","author":"E Letang","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"pone.0227600.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0180983","article-title":"A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort","volume":"12","author":"F Vanobberghen","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pone.0227600.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0116144","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland","volume":"10","author":"K Jobanputra","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"pone.0227600.ref014","doi-asserted-by":"crossref","first-page":"130627192948006","DOI":"10.1089\/aid.2011.0367","article-title":"Prevalence of Drug-Resistance Mutations and HIV-1 Subtypes in a HIV-1 Infected COHORT in rural Tanzania","volume":"29","author":"PJ Masimba","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0227600.ref015","first-page":"3","author":"V Drug HI","year":"2015","journal-title":"Major HIV-1 Drug Resistance Mutations"},{"issue":"6","key":"pone.0227600.ref016","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jiw219","article-title":"Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa","volume":"214","author":"TS Boender","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"pone.0227600.ref017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/QAI.0b013e3182615ad1","article-title":"Second-line antiretroviral therapy: long-term outcomes in South Africa","volume":"61","author":"RA Murphy","year":"2012","journal-title":"J Acquir Immune Defic Syndr JAIDS"},{"issue":"9","key":"pone.0227600.ref018","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/tmi.12741","article-title":"Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa","volume":"21","author":"MP Fox","year":"2016","journal-title":"Trop Med Int Heal"},{"issue":"9","key":"pone.0227600.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0073582","article-title":"Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria","volume":"8","author":"HE Rawizza","year":"2013","journal-title":"PLoS One"},{"key":"pone.0227600.ref020","first-page":"2016","article-title":"The need for pediatric formulations to treat children with HIV","author":"AF Schlatter","year":"2016","journal-title":"AIDS Res Treat"},{"key":"pone.0227600.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-8-89","article-title":"Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting","volume":"8","author":"M Badri","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"8","key":"pone.0227600.ref022","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-3156.2009.02309.x","article-title":"Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria","volume":"14","author":"JJG van Oosterhout","year":"2009","journal-title":"Trop Med Int Heal"},{"issue":"9","key":"pone.0227600.ref023","first-page":"1378","volume":"18","author":"DIS Rosenbloom","year":"2013","journal-title":"Therapy Outcome"},{"issue":"1","key":"pone.0227600.ref024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1473-3099(17)30630-8","article-title":"Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial","volume":"18","author":"JG Hakim","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pone.0227600.ref025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1311274","article-title":"Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa","volume":"371","author":"NI Paton","year":"2014","journal-title":"N Engl J Med"},{"key":"pone.0227600.ref026","first-page":"1","article-title":"The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates","volume":"4336","author":"MJ Siedner","year":"2017","journal-title":"HIV Clin Trials"},{"issue":"7","key":"pone.0227600.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0180761","article-title":"Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment","volume":"12","author":"O Elvstam","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pone.0227600.ref028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QAI.0000000000001479","article-title":"Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure","volume":"76","author":"M S.M","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"28","key":"pone.0227600.ref029","doi-asserted-by":"crossref","first-page":"e3985","DOI":"10.1097\/MD.0000000000003985","article-title":"Should viral load thresholds be lowered?","volume":"95","author":"ND Labhardt","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0227600.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2428-3","article-title":"Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015","volume":"17","author":"L Bulage","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T13:30:20Z","timestamp":1578922220000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227600"}},"subtitle":[],"editor":[{"given":"Joseph","family":"Fokam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227600","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.749hqz6","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}